260 Novel CLL-1-directed CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of acute myeloid leukemia

Similar Items

• P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
  by: J. Xavier-Ferrucio, et al.
  Published: (2022-06-01)
• Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
  by: John R. Lydeard, et al.
  Published: (2023-12-01)
• CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
  by: Jinghua Wang, et al.
  Published: (2018-01-01)
• Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
  by: Hui Zhang, et al.
  Published: (2020-05-01)
• The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.
  by: Anna Sävneby, et al.
  Published: (2016-01-01)